Transforming Medical Technology: The Launch of the Innovative Devices Access Pathway in the UK

By Staff Writer

September 20, 2023

A New Era of Medical Innovation

The Department of Health and Social Care (DHSC), Health Technology Wales (HTW), the Medicines and Healthcare products Regulatory Agency (MHRA), and several other health organizations have launched the Innovative Devices Access Pathway (IDAP) pilot. This new pathway, backed by £10 million of government funding, aims to fast-track patient access to innovative technologies by providing comprehensive support and advice to innovators and manufacturers.

A Pathway Paved with Potential

The IDAP is more than just a funding program. It’s a vision for the future of healthcare in the UK. The pathway aims to support the rapid development of innovative technologies that can be introduced into the National Health Service (NHS) to address unmet clinical needs. This is not just about getting new products to market quickly, but also ensuring they meet the highest standards of safety, quality, and effectiveness.

The pilot phase of the IDAP has now been launched, with innovators invited to submit Expressions of Interest for access into the pathway. Successful applicants will receive a range of support, including the development of a targeted product roadmap, system navigation advice, and support with Health Technology Assessments (HTA) for product realization and adoption.

The IDAP is open to both commercial and non-commercial innovators of medical technology in the UK and abroad. The submissions for the pilot phase opened on 19 September 2023 and will close on 29 October 2023. The future of healthcare is here, and it’s innovative, inclusive, and incredibly exciting.

Reference url

Recent Posts

Collaboration Cardiac Surgery: Boosting Surgical Volumes Through Multidisciplinary Teams

By João L. Carapinha

September 1, 2025

Cardiovascular Business recently examines how closer collaboration cardiac surgery between interventional cardiologists and cardiac surgeons can increase patient referrals for surgical interventions. This is especially important as less-invasive procedures like transcatheter interventions grow in...
Mounjaro Price Increase UK: Impacts on Access and Health Economics
Eli Lilly is raising Mounjaro's UK price by 170% on September 1, 2025. The highest dose will jump from £122 to £330 monthly. But the company has negotiated discounts with pharmacies. This will lower the effective price to £247.50. This hike aims to align international pricing as it responds to pr...
Innovative Strategies of MoonLake Immunotherapeutics HS in Targeting Inflammatory Diseases

By João L. Carapinha

August 30, 2025

MoonLake Immunotherapeutics HS, under the leadership of CEO Jorge Santos da Silva, is reimagining traditional biotech strategies with a concentrated approach to immunotherapeutic drug development. Utilizing innovative nanobody technology, the company is making strides in treating inflammatory dis...